Article
A variant of PSMD6 is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese type 2 diabetes patients.
Scientific reports - 29 May 2015
Chen Miao, Hu Cheng, Zhang Rong, Jiang Feng, Wang Jie, Peng Danfeng, Tang Shanshan, Sun Xue, Yan Jing, Wang Shiyun, Wang Tao, Bao Yuqian, Jia Weiping
Abstract excerpt
The PSMD6 variant rs831571 has been identified as a susceptibility locus for type 2 diabetes mellitus (T2DM). This study aimed to investigate the association of this variant with therapeutic effects of oral antidiabetic drugs in Chinese T2DM patients. 209 newly diagnosed T2DM patients were randomly assigned to treatment with repaglinide or rosiglitazone for 48 weeks, and the therapeutic effects were compared. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
